Universal Detection Technology,
which has, in conjunction with NASA’s Jet Propulsion Laboratories
(JPL), developed a cost-effective, unmanned, Bio-Terror “Smoke”
Detector, announced that Dr. Adrian Ponce, JPL’s lead scientist in
charge of the project and inventor of JPL’s Spore Detection
Technology, will be receiving an award for NTR (New Technology
Reporting) in relation to his work the device.

In recognition of Dr. Ponce’s contributions to the National Space
Program, and to the mission of the JPL, Dr. Ponce was contacted by the
Chairman of NASA’s Inventions and Contributions Board (ICB), that he
had been awarded a NASA Space Act Award for NTR no. 21240 30444 30469
30642 30684, “An Anthrax ‘Smoke Detector’ and related technologies.”
The award consists of a monetary award and a Certificate of

“Dr. Ponce and his staff have worked extremely hard to bring this
projected to fruition,” said Jacques Tizabi, President and CEO of
Universal Detection Technology, which holds the exclusive option on
all intellectual property related to the development of the Anthrax
“Smoke” Detector. “Everyone at UDTT has the utmost respect for Adrian
and the work he does, this award shows us that NASA recognizes the
importance of his work, work that may someday be responsible for
saving countless numbers of lives,” he concluded.

About Dr. Adrian Ponce (ponce.caltech.edu)

Dr. Ponce, California Institute of Technology Visiting Associate
in Chemistry and Senior Technical Staff Member at JPL, currently
resides as Chairman of the JPL Chemical Safety Committee and is an
active member of the JPL Science Advisory Council. He received a Ph.D.
in Chemistry from California Institute of Technology in 1999 and a
B.S. in Chemistry form Michigan State University in 1993. His Research
interests include Molecular and Mesoscale Self-Assembly, Electron
Transfer, Laser Spectroscopy, Chemical and Biological Sensors.

About NASA’s Inventions and Contributions Board (icb.nasa.gov)

The 15-member Inventions and Contributions Board (est. 1958) is a
major contributor in rewarding outstanding scientific or technical
contributions sponsored, adopted, supported, or used by NASA which are
significant to aeronautics and space activities. Chaired by NASA’s
Chief Engineer, the composition of the Board reflects NASA’s finest
technical talent whose expertise covers more than 40 fields of science
and technology.

About Universal Detection Technology (http://www.udetection.com)

Universal Detection Technology was founded in 1973
and is a developer of monitoring technologies, including bio-terrorism
detection devices. UDTT’s technology, together with third party
technologies and devices, positions the Company to capitalize on
growth and value opportunities. UDTT entered into an agreement with
NASA Jet Propulsion Laboratory (JPL) to mutually develop a
commercially available anthrax ‘smoke’ detector, which will combine
the JPL spore detection technology with Universal’s aerosol capture
device. The partnership with UDTT was accomplished through the
Technology Affiliates Program, one of many Commercial Technology
Programs aimed at transferring JPL knowledge to the private sector for
broad public use.

Except for historical information contained herein, the statements
in this news release are forward-looking statements that are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements involve
known and unknown risks and uncertainties, which may cause a company’s
actual results, performance and achievement in the future to differ
materially from forecasted results, performance, and achievement.
These risks and uncertainties include, among other things, the funding
of amounts of capital adequate to provide for the working capital
needs of the Company, our ability to timely and cost effectively
complete the development of our products targeted to the bio-chemical
and medical markets, commercial acceptance of our products, product
price volatility, product demand, market competition and general
economic conditions, and other factors described in the Company’s
filings with the Securities and Exchange Commission. We undertake no
obligation and do not intend to revise or update publicly any forward
looking statements for any reason.